What is the difference between Epitalon and Pinealon?

Target tissue and sequence. Epitalon is a four-amino-acid peptide (AEDG) studied for its action on the pineal gland, telomerase activity and circadian regulation. Pinealon is a three-amino-acid peptide (EDR) studied for its action on brain and central nervous tissue, chiefly neuroprotection and cognitive function.

If Pinealon is named after the pineal gland, why does it act on the brain?

The name is misleading. Despite the reference to the pineal, Pinealon is studied for its effects on brain and CNS tissue. Epitalon is the pineal peptide of the two.

Is Epitalon the same as Epithalamin?

Not exactly. Epithalamin is a natural pineal extract used in earlier Soviet research; Epitalon is the synthetic tetrapeptide developed from that work. Older literature often refers to the extract, newer literature to the synthetic peptide, and the two names are frequently used interchangeably when they are not identical.

Can they be studied together?

They are examined together in some research contexts because their target tissues are related — pineal signalling influences circadian rhythm, which influences brain function. They remain distinct compounds, and This library does not provide protocols or dosing guidance of any kind.

Research Library›Comparisons›Epitalon vs Pinealon

Bioregulator Comparison

Epitalon vs Pinealon: Same Family, Different Tissue

Q: Has Epitalon been shown to lengthen telomeres in humans?

Not in a completed controlled human trial. Telomerase activation and telomere elongation have been reported in human somatic cell cultures, with independent replication appearing more recently, but that is cell-culture evidence. Claims of telomere lengthening in living people go beyond what the published record currently supports.

Both are ultra-short peptides from Vladimir Khavinson’s bioregulator programme, and both are studied at the level of gene expression. What separates them is which tissue each one is designed to speak to.

7 min read·5 studies cited·Updated July 2026

Quick Reference

Epitalon	AEDG — four amino acids, pineal gland
Pinealon	EDR — three amino acids, brain tissue
Shared class	Khavinson peptide bioregulators
Shared premise	Tissue-specific gene expression
Status	Research use only — not TGA approved

The Short Answer

Both belong to the same class — ultra-short peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology, studied for acting at the level of gene expression rather than at cell-surface receptors. The design principle is tissue specificity: each sequence is intended to act on one tissue.

Tissue specificity, in plain language: if a signalling peptide is a phone call to a cell, a bioregulator is more like a letter addressed to one particular building on one particular street. The amino acid sequence is the address. Change a letter of the address and it arrives somewhere else entirely — or nowhere at all. Epitalon and Pinealon are two letters written by the same hand, in the same style, posted to different addresses: one to the pineal gland, one to brain tissue. That is why two compounds from the same family, built from almost the same handful of amino acids, are studied for quite different things.

Epitalon (AEDG, four amino acids) is the pineal peptide, and by far the better known of the two — it carries most of the telomerase research associated with the field. Pinealon (EDR, three amino acids) targets brain tissue and is studied for neuroprotection and cognitive function.

	Epitalon	Pinealon
Sequence	Ala-Glu-Asp-Gly (AEDG)	Glu-Asp-Arg (EDR)
Length	Four amino acids	Three amino acids
Target tissue	Pineal gland	Brain / CNS
Studied for	Telomerase activity, circadian regulation	Neuroprotection, cognitive function
Research volume	The most-studied Khavinson peptide	Considerably smaller literature
Naming note	Synthetic form of pineal extract Epithalamin	Named for the pineal, but acts on brain tissue

Why They Get Confused

The names invite it. Both echo the pineal gland, so it is easy to assume they are variants of one compound — but only Epitalon is a pineal peptide. Pinealon, despite its name, is studied for its action on brain and central nervous tissue.

The confusion is compounded by a genuine relationship: pineal signalling influences circadian rhythm, which in turn influences brain function, so the two research areas overlap at the edges. They remain distinct compounds with distinct targets.

A third source of muddle is Epitalon’s own history. It is the synthetic version of Epithalamin, a natural pineal extract used in earlier Soviet research. Older papers reference the extract; newer ones the synthetic tetrapeptide. Both names appear in the literature and are frequently treated as interchangeable when they are not quite.

What the Evidence Does and Does Not Show

Both sit within a research programme that is genuinely interesting and also easy to overstate, so the caveats matter as much as the findings.

Epitalon carries the field’s best-known result: telomerase activation and telomere elongation reported in human somatic cell cultures (Khavinson and colleagues, 2003), with independent replication appearing more recently. A 2017 paper confirmed the peptide occurs naturally in pineal tissue rather than existing only as a synthetic. Importantly, the telomerase work is cell-culture evidence — no completed controlled human trial has measured telomere length before and after use.

Pinealon has a smaller literature, largely preclinical, examining neuroprotection under conditions such as hypoxic stress and oxidative damage in animal and cell models.

The honest position: much of the supporting work for both compounds originates from the research programme that developed them, and broad independent replication is still limited. That is the field’s main open question rather than a reason to dismiss it.

Neither compound is approved by the TGA, FDA or EMA for any use, and both are supplied strictly as research materials.

Frequently Asked Questions

Compiled by the Southern Pacific Labs research team. Last updated July 2026.

Browse the research range →

Published References

Khavinson VKh, Bondarev IE, Butyugov AA. “Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.” Bulletin of experimental biology and medicine, 2003. PubMed
Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
Araj SK, Brzezik J, Mądra-Gackowska K, et al. “Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.” International journal of molecular sciences, 2025. PubMed
Khavinson VK, Malinin VV. “Gerontological Aspects of Genome Peptide Regulation.” Karger AG, Basel, 2005. Source
Kozina LS, Arutjunyan AV, Khavinson VKh. “Antioxidant properties of geroprotective peptides of the pineal gland.” Archives of gerontology and geriatrics, 2007. PubMed